Correlation Between Immix Biopharma and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and DiaMedica Therapeutics, you can compare the effects of market volatilities on Immix Biopharma and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and DiaMedica Therapeutics.
Diversification Opportunities for Immix Biopharma and DiaMedica Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Immix and DiaMedica is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Immix Biopharma and DiaMedica Therapeutics
Given the investment horizon of 90 days Immix Biopharma is expected to generate 2.79 times less return on investment than DiaMedica Therapeutics. In addition to that, Immix Biopharma is 1.8 times more volatile than DiaMedica Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.19 per unit of volatility. If you would invest 389.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 177.00 from holding DiaMedica Therapeutics or generate 45.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Immix Biopharma |
| DiaMedica Therapeutics |
Immix Biopharma and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and DiaMedica Therapeutics
The main advantage of trading using opposite Immix Biopharma and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Immix Biopharma vs. DiaMedica Therapeutics | Immix Biopharma vs. Lyra Therapeutics | Immix Biopharma vs. Centessa Pharmaceuticals PLC |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |